Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) will be participating in several investor conferences in March 2026, including the TD Cowen 46th Annual Health Care Conference and the Barclays 28th Annual Global Healthcare Conference. Investors interested in meeting the company’s management can contact the respective conference coordinators. A live audio webcast of the presentations can be accessed on the Events & Presentations section of the Supernus Pharmaceuticals website. The company focuses on developing and commercializing products for the treatment of central nervous system diseases, with a diverse portfolio of treatments for various conditions. For more information, visit www.supernus.com.

Read more at GlobeNewswire: Supernus Pharmaceuticals to Participate in March Investor